KORU Medical Systems Highlights Nursing Preference for FreedomEdge® at PODD Conference
KORU Medical Systems, Inc. (NASDAQ: KRMD), a prominent medical technology company specializing in innovative large-volume subcutaneous infusion solutions, recently shared data highlighting nursing preference for the KORU FreedomEdge® Infusion System for administering subcutaneous oncology infusions in clinical settings. These findings…
Parse Launches GigaLab to Scale Single-Cell Sequencing to Billions Annually
Parse Biosciences, a leader in affordable and scalable single-cell sequencing solutions, has launched Parse GigaLab™, designed to enable single-cell sequencing for billions of cells annually. GigaLab utilizes Parse’s Evercode™ technology, enhanced by an expanded workflow and increased automation, facilitating groundbreaking…
Studies Highlight Unmet Needs and Cost-Effectiveness of SSO2 Therapy for Severe Heart Attack Patients
ZOLL®, an Asahi Kasei company specializing in medical devices and software solutions, has announced the results of two significant studies on the economic burden of heart failure resulting from severe heart attacks and the long-term cost-effectiveness of SuperSaturated Oxygen (SSO2)…
IKS Health Partners with Radiology Partners to Enhance Services with Care Enablement Platform
IKS Health, a provider of healthcare enablement solutions, has partnered with Radiology Partners (RP), a leading U.S. radiology practice. This collaboration utilizes IKS Health’s Gen AI-powered Care Enablement Platform to streamline processes and enhance access to essential imaging services. The…
Castle Biosciences Highlights Cost-Saving TissueCypher® Test at ACG 2024
Castle Biosciences, Inc. (Nasdaq: CSTL) has announced new data highlighting a substantial reduction in healthcare management costs and an enhancement in the quality of life for patients with Barrett’s esophagus (BE) when their care is guided by the TissueCypher test.…
Robert Kline Joins NeuroIntact Board to Advance Temperature Management Tech
NeuroIntact Inc., a leader in targeted temperature management (TTM) for stroke and traumatic brain injury, has appointed Robert Kline to its Board of Directors. With 25 years of experience in growing innovative companies in the temperature management field, Kline will…
Relief Mental Health Expands to Middleton, WI, Offering Advanced Treatments in the Madison Area
Relief Mental Health, a leader in innovative mental health care, is thrilled to announce the opening of its 11th outpatient clinic in Middleton, Wisconsin, situated at 8333 Greenway Boulevard, Suite 240. Relief Mental Health, a leader in innovative mental health…
Dr. Howard McLeod Joins Cofactor Genomics Advisory Board as OncoPrism Test Launches in Partnered Hospitals
Cofactor Genomics, Inc., a clinical-stage company focused on bridging the precision medicine gap through RNA decoding, has announced the appointment of Dr. Howard McLeod, Pharm.D., FASCO, FCCP, to its Advisory Board. Dr. McLeod is a recognized global leader in precision…
Next Health Expands with Six New Proactive Healthcare & Longevity Centers in Sacramento, Reno, and Walnut Creek
Next Health, recognized as a leader in proactive healthcare, has announced a significant expansion into the Sacramento area, Walnut Creek, and Reno through an area development agreement. This move aligns with Next Health’s growth strategy of establishing thriving centers in…
Movemedical Teams Up with Resurgens Technology to Enhance Medical Device Supply Chain Innovation
Movemedical, a leading enterprise software platform for medical device inventory management, has announced a strategic investment partnership with Resurgens Technology Partners. This collaboration will provide essential capital to support Movemedical’s ongoing growth and expansion, advancing its mission to unify the…
Lucent Diagnostics Unveils Multi-Marker Blood Test for Early Alzheimer’s Detection
Lucent Diagnostics, a division of Quanterix Corporation (NASDAQ: QTRX), has launched LucentAD Complete, an innovative multi-marker blood test aimed at enhancing Alzheimer’s Disease (AD) detection across a wider patient population. Recent guidelines from the Alzheimer’s Association suggest using plasma p-Tau…
Elixir Medical’s DynamX Bioadaptor Outperforms Drug-Eluting Stent in Acute Coronary Syndrome Patients
Elixir Medical, known for its innovative technologies in treating cardiovascular disease, has announced compelling late-breaking data showcasing the advantages of the DynamX® Coronary Bioadaptor System over the Resolute Onyx™ zotarolimus drug-eluting stent (DES) in reducing target lesion failure (TLF) among…